UPyTher honored with KWF grant for research into metastasized ovarian cancer therapy

The startup UPyTher has been honored by the KWF with a 429,200 euro grant for additional research into the application of their gel therapy to combat metastasized ovarian cancer. UPyTher is working on a gel to deliver chemotherapy to the right place in the body to ensure a more targeted therapy.

You can read more about this here.